Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study Comparing Thymoglobulin and Grafalon for Preventing Graft Versus Host Disease in Elderly Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

    Recruiting

    1 1 1 1
    Investigated diseases:
    France
  • Study Comparing Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low-Risk Myelodysplastic Syndrome Who Are Not Dependent on Blood Transfusions

    Recruiting

    1 1 1 1
    Investigated drugs:
    Czechia France Germany Greece Hungary Italy +2
  • Study of MP0533 for Patients with Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Using Sodium Dihydrogen Phosphate Dihydrate, Polysorbate 20, and Sodium Chloride

    Recruiting

    1 1 1
    France Lithuania The Netherlands
  • Phase 1/2 Study of LB-208 in Adults with Relapsed or Refractory Acute Myeloid Leukaemia and High‑Risk Myelodysplastic Syndrome

    Not yet recruiting

    1 1
    Spain
  • A Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria France Germany Greece Hungary +8
  • Study of EP0042 alone and in combination with venetoclax and azacitidine in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML)

    Not yet recruiting

    1 1 1
    The Netherlands
  • Study on Molidustat and Ivosidenib for Adults with Relapsed or Refractory IDH1-Mutated Acute Myeloid Leukemia or Myelodysplastic Syndrome

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on the Effectiveness and Safety of Imetelstat for Patients with High-Risk Myelodysplastic Syndromes or Acute Myeloid Leukemia After HMA Therapy Failure

    Not yet recruiting

    1 1 1
    France Germany
  • Study of Natural Killer Cells and Aldesleukin for Patients with Acute Myeloid Leukemia

    Not recruiting

    1 1 1
    Investigated drugs:
    The Netherlands
  • Study of luspatercept in patients with low-risk myelodysplastic syndrome (MDS) who do not require blood transfusions and have not received erythropoiesis treatment

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany